1. Home
  2. SAIC vs RCUS Comparison

SAIC vs RCUS Comparison

Compare SAIC & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

SAIC

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

HOLD

Current Price

$133.33

Market Cap

4.5B

Sector

Technology

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$25.26

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAIC
RCUS
Founded
1969
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
3.8B
IPO Year
2013
2018

Fundamental Metrics

Financial Performance
Metric
SAIC
RCUS
Price
$133.33
$25.26
Analyst Decision
Hold
Buy
Analyst Count
8
10
Target Price
$110.50
$31.90
AVG Volume (30 Days)
463.8K
1.4M
Earning Date
06-01-2026
05-05-2026
Dividend Yield
1.56%
N/A
EPS Growth
7.39
N/A
EPS
5.00
N/A
Revenue
$7,262,000,000.00
$247,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.65
$45.62
P/E Ratio
$26.73
N/A
Revenue Growth
N/A
N/A
52 Week Low
$81.08
$12.15
52 Week High
$142.66
$31.74

Technical Indicators

Market Signals
Indicator
SAIC
RCUS
Relative Strength Index (RSI) 64.69 36.79
Support Level $123.20 $23.91
Resistance Level $142.66 $26.43
Average True Range (ATR) 4.58 1.22
MACD 0.29 -0.45
Stochastic Oscillator 52.43 26.16

Price Performance

Historical Comparison
SAIC
RCUS

About SAIC SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

Science Applications International Corp provides technical, engineering, and enterprise IT services mainly to the U.S. government. Specifically, it offers end-to-end solutions spanning the design, development, integration, deployment, management, operations, sustainment, and security of the customer's entire IT infrastructure. The company has two reportable segments, which include Defense and Intelligence and the Civilian segment. Maximum revenue is generated from its Defense and Intelligence segment, which provides a diverse portfolio of national security solutions to the DoW and the Intelligence Community of the United States Government. The Civilian segment provides solutions to the civilian markets, encompassing federal, state, and local governments.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

Share on Social Networks: